Data as of Q4 2025 (Dec 31, 2025)

Privium Fund Management B.V.

โ€ขCIK: 1795097โ€ขFiling: Q4 2025

**Privium Fund Management B.V.** manages $543M across a concentrated portfolio of 57 positions. The fund exhibits significant conviction in high-growth technology names, evidenced by its top holdings including TSLA at $102.8M and SHOP at $66.0M. Notable allocations also include substantial positions in SPOT ($39.5M), PLTR ($35.5M), and AMZN ($27.9M). This structure suggests a focused, high-beta approach targeting market leaders within the technology and digital commerce sectors.

Total AUM
$543.1M
QoQ Performance
-2.4%
Positions
57
Top 10 Concentration
68.2%
Latest Filing
Q4 2025

Top Holdings Allocation

TSLA
SHOP
SPOT
PLTR
AMZN
TSLA18.9%
SHOP12.2%
SPOT7.3%
PLTR6.5%
AMZN5.1%
ARWR4.9%
ISI3.5%
COIN3.3%

๐Ÿ“ˆ Biggest Buys

LMND
LEMONADE INC
+71.2%
3.3% of portfolio
โ€”
IREN LIMITED
+115.4%
1.9% of portfolio
VRDN
VIRIDIAN THERAPEUTICS INC
NEW
1.0% of portfolio
BIIB
BIOGEN INC
+41.5%
2.4% of portfolio
ENGN
ENGENE HOLDINGS INC
NEW
0.6% of portfolio

๐Ÿ“‰ Biggest Sells

SPOT
SPOTIFY TECHNOLOGY S A
-28.4%
7.3% of portfolio
TSLA
TESLA INC
-6.4%
18.9% of portfolio
AMZN
AMAZON COM INC
-18.8%
5.1% of portfolio
ARWR
ARROWHEAD PHARMACEUTICALS IN
-16.0%
4.9% of portfolio
MRK
MERCK & CO INC
-43.2%
0.7% of portfolio

Sector Breakdown

Other62.4%
Consumer24.1%
Communication7.3%
Technology5.1%
Healthcare0.9%
Energy0.3%

๐Ÿšช Exited Positionssold since Q3 2025

ABVX
ABIVAX SA
SOLD
$2.6M
RNAGBP
AVIDITY BIOSCIENCES INC
SOLD
$2.3M
ROIV
ROIVANT SCIENCES LTD
SOLD
$1.9M
ACAD
ACADIA PHARMACEUTICALS INC
SOLD
$1.5M
ALXO
ALX ONCOLOGY HLDGS INC
SOLD
$931.6K
+3 more exited positions

Changes from Q3 2025

NEW6 new positions
โ†‘25 increased
โ†“15 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023